ETF Managers Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,654
Closed -$1.62M 747
2021
Q4
$1.62M Sell
10,654
-763
-7% -$103K 0.03% 229
2021
Q3
$1.37M Buy
+11,417
New +$1.26M 0.03% 238

Other funds holding TNDM

ETF Managers Group's TNDM Position: Q1 2022 in Review

ETF Managers Group sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 10,654 shares — an estimated $1.62M sold.

ETF Managers Group first reported a position in TNDM in Q3 2021 and held it in 2 quarters. The position peaked at $1.62M in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • ETF Managers Group reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • ETF Managers Group sold 10,654 Tandem Diabetes Care shares in Q1 2022, an estimated $1.62M.
  • ETF Managers Group first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 2 quarters.
  • ETF Managers Group's Tandem Diabetes Care position peaked at $1.62M in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on ETF Managers Group's 13F filing for Q1 2022, filed 13 May 2022.